Shoreline Biosciences

Shoreline Biosciences Establishes Safe, Effective, and Affordable Cellular Immunotherapies for Treating Critically Ill Patients. With innovative thinking and a resilient spirit, we are committed to discovering and developing clinically effective immunotherapies using intelligently engineered iPSC-derived allogeneic cells to save lives. The company's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway to enhance metabolic fitness and persistence of engineered NK cells, thereby improving anti-cancer activity.